Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 799

Results For "IT"

11219 News Found

Ministry of Ayush inaugurates the conference on Homeopathy in Kolkata
News | October 06, 2023

Ministry of Ayush inaugurates the conference on Homeopathy in Kolkata

The World Homoeopathy Day commemorates the birth anniversary of Dr Samuel Hahnemann on 10th of April


Apollo launches Hyderabad's first homecare recovery program
News | October 06, 2023

Apollo launches Hyderabad's first homecare recovery program

This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients


Asahi Kasei Pharma files application for approval to manufacture and sell Cresemba Capsule
Drug Approval | October 05, 2023

Asahi Kasei Pharma files application for approval to manufacture and sell Cresemba Capsule

The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg


Emmes appoints Matt Bond as CFO
People | October 05, 2023

Emmes appoints Matt Bond as CFO

His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy


Marksans Pharma gets USFDA approval for Esomeprazole Magnesium delayed-release capsules
Drug Approval | October 05, 2023

Marksans Pharma gets USFDA approval for Esomeprazole Magnesium delayed-release capsules

This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals


Alembic received 6 USFDA approvals during Q2FY24
Drug Approval | October 05, 2023

Alembic received 6 USFDA approvals during Q2FY24

The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets


Lupin launches patient support program ‘Humrahi‘  for diabetes management
Healthcare | October 04, 2023

Lupin launches patient support program ‘Humrahi‘ for diabetes management

India has the highest prevalence of diabetes globally, with an estimated 77 million people living with the condition and an expected 134 million cases by 2045


Strides receives USFDA approval for Icosapent Ethyl capsules
Drug Approval | October 04, 2023

Strides receives USFDA approval for Icosapent Ethyl capsules

The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin


AstraZeneca Pharma India gets permission to import Palivizumab solution for injection
News | October 03, 2023

AstraZeneca Pharma India gets permission to import Palivizumab solution for injection

Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus


Zydus announces IND clearance of a novel Anti-PCSK9 candidate
Clinical Trials | October 03, 2023

Zydus announces IND clearance of a novel Anti-PCSK9 candidate

Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity